-- 根據美國商品期貨交易委員會(CFTC)每週發布的交易商持股報告(COT報告),基金經理在豆油期貨和選擇權市場仍保持看漲或淨多頭部位。 截至4月7日當週的COT報告顯示,基金經理在加州低碳燃料標準(CLSF)市場持有62,703份合約的淨多頭頭寸,押注市場將上漲。而生產商、貿易商、加工商和用戶則持有80,902份合約的淨空頭寸,押注市場將下跌。 COT報告也顯示,基金經理在D6再生能源識別碼(RIN)當年期貨和選擇權市場持有1,650份合約的淨多頭頭寸,而生產商、貿易商、加工商和用戶則持有1,322份合約的淨多頭頭寸。 在D4生物柴油RINS本年度期貨和選擇權市場,基金經理持有3,590份淨多頭頭寸,而生產商、貿易商、加工商和用戶則持有2,599份淨空頭頭寸。 乙醇方面,基金經理人在期貨和選擇權市場持有7,317份淨多頭部位。生產商、貿易商、加工商和使用者則持有7,967份淨空頭部位。 在大豆油期貨和選擇權市場,基金經理持有150,682份淨多頭頭寸,較一週前增加了10,686份多頭頭寸,並減少了4,187份空頭頭寸。生產商、貿易商、加工商和使用者則持有273,778份淨空頭部位。 外部投資者在太陽能替代能源信貸市場持有2,370份淨多頭頭寸,而生產商、貿易商、加工商和用戶則持有8,345份淨空頭頭寸。 資金管理者目前淨做空馬來西亞棕櫚油期貨579份合約。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.